Results 71 to 80 of about 6,488,856 (287)

Are percutaneous coronary interventions changing our coronary surgery practice? [PDF]

, 2010
Aim: The aim of this retrospective study was to assess the impact of a growing percutaneous coronary intervention (PCI) program on our coronary artery bypass graft (CABG) practice.
Manche, Alexander, Casha, Aaron
core  

Final 2‐Year Results of the REFORM Study: A Randomized Trial of Biolimus DCB Versus Paclitaxel DCB for In‐Stent Restenosis

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In the REFORM trial, treatment of coronary in‐stent restenosis with a Biolimus A9™ drug‐coated balloon (BCB) was found to be inferior with respect to in‐segment percentage stenosis at 6‐months in comparison to treatment with a standard paclitaxel coated paclitaxel‐coated balloon (PCB). Aims In this manuscript, the final prespecified
Daniel O'Callaghan, J. J. Coughlan, Fernando Alfonso, Joo‐Yong Hahn, Manel Sabate, Ralph Toelg, Samuel Copt, Sean Fitzgerald, Marie‐Claude Morice, Jasper Trevelyan, Darren Mylotte, Antonio Fernandez Ortiz, Rory Durand, Jochen Wöhrle, Franz Xever Kleber, Giuilo Stefanini, Himanshu Rai, Peter O'Kane, Robert A. Byrne   +18 more
wiley   +1 more source

Buddy Wire–Augmented Intravascular Lithotripsy in Refractory Calcified Coronary Lesions: A Five‐Case Series

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Heavily calcified coronary lesions remain a major challenge in percutaneous coronary intervention (PCI), often limiting the effectiveness of intravascular lithotripsy (IVL). We report a five‐case series in which IVL failed to achieve adequate lesion modification but was successfully augmented by the addition of one or more buddy wires.
Alfredo Marchese, Mattia Squillace, Pierluigi Demola, Giuseppe Speziale, Francesco Bedogni, Robert J. Chilton   +5 more
wiley   +1 more source

Giant mycotic RCA aneurysm -A very rare complication of PCI

IHJ Cardiovascular Case Reports, 2018
Infected giant coronary artery aneurysm is a very rare complication of percutaneous coronary intervention (PCI). We report a patient with giant mycotic right coronary artery aneurysm after primary PCI, who underwent early surgical intervention with ...
Laxmi H. Shetty, DNB, DM, B. Ashalatha, MD, DM, Kumsi Sreedhar, MS, Mch, Cholenahally Nanjappa Manjunath, MD, DM   +3 more
doaj   +1 more source

Arterial access site in the catheterisation lab : Is radial the way to go? [PDF]

, 2013
Aim: With radial access increasing in popularity in the United States and the United Kingdom, this literature review explores whether radial access in coronary angiography and percutaneous coronary intervention is superior to femoral access, focusing on ...
Cassar, Mark Philip
core  

Percutaneous coronary intervention for stable coronary artery disease [PDF]

, 2008
Patients with significant coronary artery stenoses are at increased risk of future cardiac events. However, in the absence of acute coronary syndrome or recent myocardial infarction and residual ischemia, elective percutaneous coronary intervention has ...
Katritsis, Demosthenes G, Katritsis, Demosthenes G., Meier, Bernhard   +2 more
core   +1 more source

Sheath‐to‐Artery Diameter Ratio: A Robust Predictor of Early Access‐Site Adverse Events in Percutaneous Procedures

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Vascular access site complications (VASCs) remain an important source of morbidity following percutaneous interventions. Although the sheath‐to‐femoral artery ratio is a recognized risk factor in transcatheter aortic valve implantation (TAVI), its role across a broader range of femoral procedures is less well defined.
Eduardo Ismael Arteaga Chan, Claudia Lerma, Adriana Torres‐Machorro   +2 more
wiley   +1 more source

Clinical Outcomes of the Allegra Transcatheter System in Bioprosthetic Aortic Valve Failure: A Multicentre Valve‐in‐Valve Registry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Introduction The prevalence of bioprosthetic aortic valve failure is increasing due to the broader use of bioprosthetic valves, both surgical and transcatheter, and an ageing population. Registry data indicate a higher risk of coronary obstruction and elevated gradients following valve‐in‐valve transcatheter aortic valve implantation (TAVI ...
Hilal Khan, Mohamed Ali, Abdalazeem Ibrahem, Karim Ratib, Nur Ilia Mohd Zaki, Freidoon Keshavarzi, Alok Shah, Hesham Abdelaziz, Ayush Khurana, Alexander Chase, Diana A. Gorog, Rajiv Das, Azfar Zaman, Mohammad AlKhalil, Mohamed Farag   +14 more
wiley   +1 more source

Physiology‐Guided Drug‐Coated Balloon Angioplasty: What We Know and What is Yet to be Understood

Catheterization and Cardiovascular Interventions, EarlyView.
Marco Frazzetto, Filippo Luca Gurgoglione, Bharat Khialani, Sandeep Basavarajaiah, Bernardo Cortese   +4 more
wiley   +1 more source

Clinical Outcomes of Drug‐Eluting Stents and Drug‐Coated Balloons in Tortuous Small Coronary Lesions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In small, tortuous coronary lesions, the long‐term comparative performance of drug‐coated balloon (DCB) angioplasty versus drug‐eluting stent (DES) treatment remains uncertain, despite both strategies being widely used in contemporary percutaneous coronary intervention (PCI) practice. Aims This study aimed to compare 3‐year clinical
Shunichiro Ishio, Takashi Nagasaka, Ryota Taniuchi, Shiro Amanai, Yohei Ishibashi, Noriaki Takama, Hideki Ishii   +6 more
wiley   +1 more source